Skip to content

A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19

Assessing Behavioral, Functional, and Clinical Patient-Reported Outcomes (PROs) in Subjects Diagnosed With COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05042232
Enrollment
239
Registered
2021-09-13
Start date
2021-04-19
Completion date
2022-06-14
Last updated
2022-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 Acute Respiratory Disease

Brief summary

The primary objective of this study is to identify and describe patient behaviors and clinical outcomes among patients who have tested positive for mild to moderate COVID-19.

Detailed description

This virtual observational cohort study will describe patient behaviors and clinical outcomes of subjects who tested positive for COVID-19. Among those with positive tests, predictors of time to recovery, post-COVID function and outcomes will be identified. Individuals who test negative and positive for SARS-CoV-2 will be enrolled in the study.

Interventions

OTHERSARS-CoV-2 Positive

Participants who have tested positive for SARS-CoV-2, both with and without symptoms

OTHERSARS-CoV-2 Negative

Participants who have tested negative for SARS-CoV-2

Sponsors

Everly Health
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \>=18 years * Individuals with a valid diagnostic COVID-19 test result

Exclusion criteria

\- Unable or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frame
To identify and describe patient behaviors and clinical outcomes among patients who have tested positive for COVID-19Up to 12 months

Secondary

MeasureTime frame
To describe recovery in patients with test-confirmed COVID-19 infection including time to recovery and functional improvementUp to 12 months
To develop prediction tools for time to recovery, function and outcomes in patients with COVID-19 identified by home testingUp to 12 months
To describe users and the utilization of COVID-19 home testing over time by geography, demographics, and comorbidityUp to 12 months
To describe the feasibility of COVID-19 home testingUp to 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026